Leodevico L. Ilag PhD

Dr. Ilag has more than 20 years of biotech experience in the discovery and development of biologics and diagnostics serving in multiple senior executive roles with several biotech companies in Australia and Europe. He has extensive research and technical experience in the discovery, preclinical and clinical development of biologics and dietary/food ingredients (peptides, antibodies, natural products, agricultural waste streams) with applications in oncology, cardiovascular disease, CNS, infectious disease, and metabolic disease. He obtained his PhD in Microbiology/Immunology from the University of Tennessee Center for the Health Sciences in 1991 and did postdoctoral studies at Purdue University in structural biology until 1994. He is the Chief Scientific Officer of Xerion Limited since 2014.